Patients may experience localized pain with later radiating symptoms to adjacent portions of the back, extremity weakness, sensory deficits, gait disturbances, and incontinence
Once you have your card, use it at the pharmacy to save on Wegovy
Yes, itching can be a side effect of semaglutide, though it is less common
#GLP1 #Wegovy #Mounjaro #WeightLossClinics #TelemedicineUK #HealthcareUK #PharmacyPartner UK GLP-1 surge: How clinics can meet demand and avoid delays UK GLP-1 Surge- What Clinics Must Know: Recent data from Grand View Research shows that GLP-1 users in the UK have jumped from 2.3% in March 2024 to 4.1% today The UK weight-loss GLP-1 market is projected to reach US$715 million by 2030, growing at a 17.7% CAGR from 2025 to 2030
SH: Writing original draft, Writing review & editing
Citation: Vukojevi, J., Kolenc, D., Brcic, I., & Seiwerth, S